-
VRTX Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
Vertex Pharmaceuticals (VRTX)
Company Profile
Quarter (USD) | Dec 24 | Sep 24 | Jun 24 | Mar 24 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 4.57 bn | 4.57 bn | 4.57 bn | 4.57 bn | 4.57 bn | 4.57 bn |
Cash burn (monthly) | 225.30 mm | 483.34 mm | (no burn) | (no burn) | (no burn) | 41.05 mm |
Cash used (since last report) | 468.59 mm | 1.01 bn | n/a | n/a | n/a | 85.38 mm |
Cash remaining | 4.10 bn | 3.57 bn | n/a | n/a | n/a | 4.49 bn |
Runway (months of cash) | 18.2 | 7.4 | n/a | n/a | n/a | 109.3 |
13F holders | Current |
---|---|
Total holders | 1499 |
Opened positions | 183 |
Closed positions | 203 |
Increased positions | 538 |
Reduced positions | 590 |
13F shares | Current |
---|---|
Total value | 89.94 tn |
Total shares | 235.18 mm |
Total puts | 1.44 mm |
Total calls | 1.61 mm |
Total put/call ratio | 0.9 |
Largest owners | Shares | Value |
---|---|---|
Capital World Investors | 28.33 mm | $11.41 tn |
Vanguard | 23.26 mm | $9.37 tn |
BlackRock | 21.83 mm | $8.79 tn |
STT State Street | 11.98 mm | $4.82 tn |
Capital Research Global Investors | 10.43 mm | $4.20 tn |
FMR | 9.22 mm | $3.71 tn |
JPM JPMorgan Chase & Co. | 6.31 mm | $2.54 tn |
Wellington Management | 5.92 mm | $2.38 tn |
Geode Capital Management | 5.65 mm | $2.27 tn |
Jennison Associates | 4.32 mm | $1.74 tn |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
27 Feb 25 | Altshuler David | Common Stock | Sell | Dispose S | No | Yes | 480 | 1,272 | 610.56 k | 32,974 |
27 Feb 25 | Edward Morrow Atkinson III | Common Stock | Sell | Dispose S | No | Yes | 475.34 | 2,650 | 1.26 mm | 19,352 |
26 Feb 25 | Altshuler David | Common Stock | Payment of exercise | Dispose F | No | No | 479.61 | 5,954 | 2.86 mm | 34,246 |
26 Feb 25 | Kristen Ambrose | Common Stock | Payment of exercise | Dispose F | No | No | 479.61 | 1,241 | 595.20 k | 7,845 |
26 Feb 25 | Edward Morrow Atkinson III | Common Stock | Payment of exercise | Dispose F | No | No | 479.61 | 2,482 | 1.19 mm | 22,002 |
26 Feb 25 | Bozic Carmen | Common Stock | Payment of exercise | Dispose F | No | No | 479.61 | 4,962 | 2.38 mm | 32,669 |
26 Feb 25 | Kewalramani Reshma | Common Stock | Payment of exercise | Dispose F | No | No | 479.61 | 14,079 | 6.75 mm | 105,915 |